tiprankstipranks
Advertisement
Advertisement
Nektar rises 28.2%
PremiumThe FlyNektar rises 28.2%
20d ago
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
Premium
The Fly
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
20d ago
Nektar rises 19.4%
Premium
The Fly
Nektar rises 19.4%
20d ago
Citi opens ‘upside 30-day catalyst watch’ on Nektar into data
PremiumThe FlyCiti opens ‘upside 30-day catalyst watch’ on Nektar into data
1M ago
Nektar Therapeutics: Buy Rating on Favorable Alopecia Areata Rezpeg Data Outlook and 30‑Day Catalyst Upside Potential
Premium
Ratings
Nektar Therapeutics: Buy Rating on Favorable Alopecia Areata Rezpeg Data Outlook and 30‑Day Catalyst Upside Potential
1M ago
Nektar Therapeutics Faces Investor Lawsuit Over Alleged Clinical Trial Enrollment Failures and Stock Decline
Premium
Class Action
Nektar Therapeutics Faces Investor Lawsuit Over Alleged Clinical Trial Enrollment Failures and Stock Decline
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100